Effect of Propolis on the Isolated Bacterial Infection on Covid-19 patient in Erbil City-Iraq
DOI:
https://doi.org/10.53350/pjmhs02025193.3Keywords:
COVID-19, Klebsiella spp., Staphylococcus aureus, Pseudomonas spp., E. coli, Propolis, Antibacterial activity.Abstract
Background: Propolis, a resin-like substance collected by honeybees, has long been known for its antimicrobial capabilities.
Aim: To explore the antibacterial potential of ethanolic propolis extracts (EEP) against bacterial isolates obtained from COVID-19-infected patients in Erbil, Iraq.
Methods: Clinical samples were obtained from 50 confirmed COVID-19 patients admitted to the Emergency Management Center (EMC) in Erbil. Standard microbiological methods were used for bacterial isolation and identification. Propolis extracts at a concentration of 1500 µg/mL were applied in wells on culture plates, and antibacterial activity was assessed by measuring zones of inhibition.
Results: Out of 50 samples, 39 yielded positive bacterial cultures while 11 showed no bacterial growth. Among the isolates, 7 were Gram-positive and 23 were Gram-negative. Klebsiella species were the most frequently isolated Gram-negative pathogens, followed by E. coli and Pseudomonas spp. Staphylococcus aureus was the dominant Gram-positive isolate. No methicillin-resistant S. aureus (MRSA) strains were detected. The study demonstrated variable inhibition zones in response to different EEP concentrations.
Conclusion: The ethanolic extract of propolis exhibited significant antibacterial effects against both Gram-positive and Gram-negative bacteria isolated from COVID-19 patients. The inhibition varied depending on bacterial species and EEP concentration.
References
Habib, G., Mahmood, K., Gul, H., Tariq, M., Ain, Q.U., Hayat, A. and Rehman, M.U., 2022. Pathophysiology of Methicillin-Resistant Staphylococcus aureus Superinfection in COVID-19 Patients. Pathophysiology, 29(3), pp.405-413.
Holshue, M.L., DeBolt, C., Lindquist, S., Lofy, K.H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A. and Diaz, G., 2020. First case of 2019 novel coronavirus in the United States. New England journal of medicine.
LontsiNgoula, G., Houcke, S., Matheus, S., Nkontcho, F., Pujo, J.M., Higel, N., Ba, A., Cook, F., Gourjault, C., Mounier, R. and Nacher, M., 2022. Impact of Antibiotic Consumption on the Acquisition of Extended-Spectrum β-Lactamase Producing Enterobacterales Carriage during the COVID-19 Crisis in French Guiana. Antibiotics, 12(1), p.58.
Manohar, P., Loh, B., Athira, S., Nachimuthu, R., Hua, X., Welburn, S.C. and Leptihn, S., 2020. Secondary bacterial infections during pulmonary viral disease: phage therapeutics as alternatives to antibiotics?. Frontiers in Microbiology, p.1434.
Morris, D.E., Cleary, D.W. and Clarke, S.C., 2017. Secondary bacterial infections associated with influenza pandemics. Frontiers in microbiology, 8, p.1041.
Morris, D.E., Cleary, D.W. and Clarke, S.C., 2017. Secondary bacterial infections associated with influenza pandemics. Frontiers in microbiology, 8, p.1041.
Russell, C.D., Fairfield, C.J., Drake, T.M., Turtle, L., Seaton, R.A., Wootton, D.G., Sigfrid, L., Harrison, E.M., Docherty, A.B., de Silva, T.I. and Egan, C., 2021. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. The Lancet Microbe, 2(8), pp.e354-e365.
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y. and Zhao, Y., 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. jama, 323(11), pp.1061-1069.
Wang, H., Anthony, D., Selemidis, S., Vlahos, R. and Bozinovski, S., 2018. Resolving viral-induced secondary bacterial infection in COPD: a concise review. Frontiers in immunology, 9, p.2345.
CLSI, C., 2016. Performance standards for antimicrobial susceptibility testing. Clinical Lab Standards Institute.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2025 SHLER QASIM HUSSIEN
This work is licensed under a Creative Commons Attribution 4.0 International License.
